What Are the Hedge Fund Masters of the Universe Buying?
Here are five stocks that I think are worth a look. See if you agree with me.

Investing is one of those rare disciplines in which it really doesn’t pay to be original. This is money, not literature. They don’t award Pulitzer Prizes for original investing ideas.
You don’t want to mindlessly follow the herd, of course. That rarely ends well. Before you copy the trading moves of another investor, you need to do a little homework of your own, and you should always maintain an independent, skeptical mind when putting your capital at risk. But you don’t get bonus points for coming up with an original trade. Returns are returns, regardless of whose idea the trade was, so there is really no sense in reinventing the wheel.
Today, we’re going to take a look at some of the most recent major trades by some of the smartest investors in the business. Not all of these are trades I would recommend myself. In fact, at least one of them is a stock I would run away from--screaming. But it’s worthwhile to track which stocks the masters of the universe are buying. Even if we don’t invest along with them on every trade, we might learn a thing or two.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Cheniere Energy
Let’s start with liquefied natural gas exporter Cheniere Energy (LNG). With the price of crude oil under major pressure in 2015, energy stocks – Cheniere included – have taken an absolute beating. Cheniere is down over 40% from its 52-week high. Yet some of the smartest investors of our lifetimes are backing up the proverbial truck and loading it up with Cheniere.
Last quarter, Seth Klarman – a value investor that most other value investors consider to be an a god-like figure – increased his already massive position in Cheniere by nearly half. (See Investing Legends: Baupost’s Seth Klarman)
Klarman runs a highly-concentrated portfolio; so highly concentrated, in fact, that his top five stocks make up more than half the portfolio. Cheniere now makes up fully 18% of Klarman’s portfolio, and Klarman owns 22 million shares at an average cost basis of $63.57 per share.So at today’s price of about $48 per share, you could get a better deal than Klarman, a man universally recognized as one of the savviest value investors to ever play the game.
And Klarman isn’t the only legend aggressively buying Cheniere. Carl Icahn has been aggressively accumulating the shares and bought 27 million shares last quarter at an average price of $61.88 per share. And since the end of the quarter, he’s continued to average down, buying an additional 1.3 million in the mid-$40s. So today, you can buy Cheniere at a better price than Mr. Icahn as well.
What do these legends see in Cheniere, amidst the carnage in the energy market? They’re looking ahead. If you are a European or Asian energy importer, would you feel comfortable trusting your country’s gas supply to Vladimir Putin’s Russia or to the volatile Middle East? Me neither.
If you believe that American gas exports make sense, then Cheniere makes sense.
Mondelez International
Up next is snack food giant Mondelez International (MDLZ), the owner of the Nabisco, Cadbury and Oreo brands, among others.
As I wrote recently (see “Coke in the Crosshairs”) junk food today is somewhat reminiscent of cigarettes 30 years ago. Regulators and activists are blaming junk food companies for everything from childhood obesity to adult-onset diabetes.
But just as Big Tobacco stocks have often been some of the best stocks to buy despite the onslaught of bad publicity against them, junk food stocks might also represent a good opportunity. Perhaps that is Pershing Square boss Bill Ackman’s rationale for making a major investment in Mondelez last quarter. Ackman bought 43 million shares, making Mondelez his fourth-largest holding at 13% of his long portfolio.
Like Seth Klarman, Bill Ackman tends to run a highly concentrated portfolio in which he bets big on a very small handful of stocks. When it works, it works fantastically well. Ackman’s hedge fund earned returns in excess of 40% last year.
Alas, running a concentrated portfolio is not without its risks. Ackman’s fund is down about 20% this year, due in large part to its overweighted position in Valeant Pharmaceuticals (VRX).
So, is Ackman’s bet on Mondelez likely to pan out? Based on the prices he paid, I think chances are good. Mondelez trades for just 8 times trailing earnings.
Apple
Up next is one of my personal favorites, consumer electronics king Apple (AAPL). Carl Icahn is probably the highest-profile Apple bull out there. Icahn has about 20% of his portfolio allocated to Apple, and he’s been the loudest voice calling for Apple to return cash to shareholders via dividend hikes and aggressive share repurchases.
But Icahn now has company from fellow hedgie David Einhorn, who increased his already enormous position in Apple by more than half last quarter. Einhorn now owns 11 million shares, making Apple about 20% of his long portfolio.
Apple, as the largest company in the world by market cap, is naturally going to be widely held by large money managers. But putting 20% of your portfolio into a single stock is a bold move. And given the general sense of bearishness towards Apple these days, is it the right statement?
Here’s my view: It’s fair to say that Apple is no longer the growth dynamo it was five years ago. The smartphone market, at least in the developed world, is largely saturated. So at this point, most iPhone sales are replacements rather than new purchases. iPad sales have been disappointing for several quarters, and Apple’s newer products – such as the Apple Watch and Apple Pay – haven’t been blockbusters.
Guess what? At today’s prices, none of that actually matters. Apple is not being priced as a growth dynamo. In fact, at 12 times trailing earnings, it’s being priced as a no-growth company. Meanwhile, the S&P 500 trades for 21 times trailing earnings.
That’s absurd. In a broadly expensive market, it makes no sense that Apple trades at such a deep discount. I would follow Icahn and Einhorn here.
Alphabet
Up next, we have Apple’s rival in the smartphone wars, Alphabet (formerly Google, GOOGL).2015 has been the year of the “FANGs,” in which a small handful of stocks – specifically Facebook (FB), Amazon (AMZN)Netflix (NFLX) and Google have been responsible for keeping the market averages afloat.
Perhaps this is what convinced Leon Cooperman to massively increase his stake in Alphabet last quarter. Cooperman bought 213,659 shares of Alphabet in the second quarter and then more than doubled his holdings with a 269,090-share purchase in the third.
Cooperman, who heads Omega Advisors, does not run as concentrated a portfolio as some of the other gurus I’ve covered today. But Alphabet is now his largest holding and makes up a very respectable 6% of his portfolio.
Alphabet is not particularly cheap, trading at 31 times trailing earnings. Also, and much to my chagrin, Alphabet does not pay a dividend, which I consider almost criminal for a company of Alphabet’s size.
Still, Alphabet has been one of the few bright spots this year in a market that has been mostly disappointing, particularly for value investors. If you’re a momentum investor, then by all means, buy Alphabet and ride it higher. Just be prepared to sell when the market gets fickle and turns its affections elsewhere.
International Business Machines
And finally, we get to International Business Machines (IBM), a long-time holding by Warren Buffett. Buffett added about 1.5 million shares to his IBM position last quarter, and it is now his fourth-largest holding.
Buffett is also losing his shirt on IBM. He owns 81 million shares at an average price of $172 per share. At time of writing, IBM trades for just $134.45.
Buffett’s ownership of Big Blue is old news. But he now has company in the trade. Last quarter, Bruce Berkowitz and Eddie Lampert each made new purchases of IBM. Berkowitz bought 754,000 shares, making IBM a modest 3% of his portfolio. Lampert bought 440,225 shares, making it about 4% of his portfolio.
I don’t claim to be smarter than Buffett, Berkowitz or Lampert. But I don’t intend to follow them into this trade either. IBM’s business appears to be falling apart. Revenues have been falling for three straight years with no end in sight, and IBM has been slow to compete with more flexible cloud rivals Amazon, Alphabet and Microsoft (MSFT).
So, what do these storied value investors see in IBM? It is a cheap stock at current prices, trading for just 9 times trailing earnings. But remember, those earnings are inflated by IBM’s aggressive share repurchases, and cheap stocks can stay cheap forever in the absence of a catalyst to send them higher.
Frankly, I see no catalyst for IBM right now. After the tumble the stock has taken, a dead-cat bounce is a real possibility. But if I’m going to make a long-term bet in this space, I’d put my money on Microsoft instead.
Disclosures: Long AAPL, MSFT.
Charles Lewis Sizemore, CFA, is chief investment officer of the investment firm Sizemore Capital Management and the author of the Sizemore Insights blog.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Charles Lewis Sizemore, CFA is the Chief Investment Officer of Sizemore Capital Management LLC, a registered investment advisor based in Dallas, Texas. Charles is a frequent guest on CNBC, Bloomberg TV and Fox Business News, has been quoted in Barron's Magazine, The Wall Street Journal, and The Washington Post and is a frequent contributor to Yahoo Finance, Forbes Moneybuilder, GuruFocus, MarketWatch and InvestorPlace.com.
-
The Trump GOP Tax Bill Could Worsen California Cost of Living
State Tax Energy bills in the Golden State may shock you if Republican lawmakers in Congress remove certain energy tax credits through Trump's 'big, beautiful bill.'
-
The Best Covered-Call ETFs to Buy
Covered-call ETFs can provide consistent, above-average income generation, but they can also cap potential upside. Here's what to look for.
-
Wealth Advisers: In Estate Planning, the End Is Just the Beginning
We need to keep the lines of communication with our clients open so that we can anticipate and help them navigate issues that arise over time.
-
Stood Up by a Radio Show: But Was It a Breach of Contract?
A conscientious financial planner reschedules his clients after being invited onto a talk show and ends up losing one of them at a cost of $5,000. What does the radio show owe him, if anything?
-
Eight Estate Planning Steps to Protect Your Loved Ones (and Your Legacy)
Two-thirds of Americans don't have an estate plan. If you're one of them, these are the essential steps to take now to prevent problems for your family later.
-
The Six Pros This Adviser Says You Need to Sell Your Business
Selling your business isn't as simple as getting the best price and walking away. These are the six professionals you'll need to get a deal across the finish line.
-
The Three C's to Financial Success: A Financial Planner's Guide to Build Wealth
Consistency, commitment and confidence in your chosen strategy are more critical to your financial success than finding the 'perfect' financial plan.
-
A Financial Adviser's Guide to Solving Your Retirement Puzzle: Five Key Pieces
If retirement's a puzzle you're struggling with, try answering these five questions. The answers will guide you toward a solution.
-
You're Close to Retirement and Cashed Out: How Do You Get Back In?
If you've been scared into an all-cash position, it's wise to consider reinvesting your money in the markets. Here's how a financial planner recommends you can get back in the saddle.
-
After the Disaster: An Expert's Guide to Deciding Whether to Rebuild or Relocate
Homeowners hit by disaster must weigh the emotional desire to rebuild against the financial realities of insurance coverage, unexpected costs and future risk.